The compound identity ethyl 2-[(tert-butoxycarbonyl)amino]thiazole-4-carboxylate (CAS 302964-05-8; molecular formula C11H16N2O4S; molecular weight 272.32 g·mol−1) is supplied as a crystalline solid with a typical melting range of 104–107 °C by differential scanning calorimetry at a ramp rate of 10 K·min−1 under nitrogen. The product is delivered with an assay of ≥98.5% (HPLC, area-%, detection at 254 nm; method adapted from general monograph 2.2.29 of Ph. Eur. 11.0) and complies with residual solvent limits according to ICH Q3C(R8) Table 2 for Class 2 solvents, as confirmed by headspace GC-FID. Its primary utility lies in convergent synthesis sequences where orthogonal protection of the 2-amino group with a tert-butoxycarbonyl (Boc) moiety enables selective deprotection under acidic conditions without rupture of the ethyl ester, a design feature that distinguishes it from the corresponding methyl ester in multi-step routes to thiazole-containing pharmacophores.
A Dual-Functional C4-Carboxylate Synthon with Latent Nucleophilic Reactivity at C2
In process-scale amidation campaigns, the ethyl ester functions as an electrophilic handle for direct coupling with primary amines to furnish N-Boc-protected thiazole-4-carboxamides. Pilot-plant batches employing a 50 L jacketed glass reactor with pitched-blade turbine agitation (tip speed 1.2 m·s−1) have demonstrated that pre-dissolution of the thiazole ester in tetrahydrofuran (water content ≤200 ppm by Karl Fischer titration) at 0.45–0.55 M concentration, followed by slow addition of 1.05 equiv of a lithium amide generated in situ from the amine and n-butyllithium at −20 °C, yields the protected carboxamide in 88–92% isolated yield after aqueous work-up and crystallization from n-heptane/ethyl acetate (4:1 v/v). The Boc group remains intact under these conditions, as verified by 1H-NMR monitoring (disappearance of the ethyl ester quartet at 4.35 ppm in CDCl3), and any premature deprotection is limited to <2% when the reaction pH is maintained above 8 units. Conversely, the amino function liberated by acidolysis (4 M HCl in 1,4-dioxane, 20–25 °C, 4 h) can engage in reductive amination with aromatic aldehydes using sodium triacetoxyborohydride (1.5 equiv) in dichloromethane containing 3% acetic acid, providing secondary amines without transesterification of the ester, a pathway not accessible with the more labile methyl ester under the same protocol.
The stability profile of the product under recurrent downstream unit operations mandates strict environmental control. When exposed to relative humidity above 60% at 30 °C for 72 h, the crystalline powder absorbs up to 2.8 wt% water (dynamic vapour sorption, SMS DVS Intrinsic analyser), triggering partial surface hydrolysis of the Boc group to yield 2-aminothiazole-4-carboxylate, detected at 3.2% by HPLC. Consequently, handling in open vessels is limited to facilities where the dew point is kept below −10 °C, and all blending or sub-division operations are performed in glove boxes purged with dry nitrogen (oxygen <0.5%, moisture <1 ppm). Double polyethylene liners with aluminium foil moisture-barrier bags are specified for 1 kg and 25 kg fill volumes, and the re-test date is set at 24 months when stored continuously at 2–8 °C per accelerated stability testing modelled on ICH Q1A(R2). Under these conditions, assay drift is ≤0.3% and total related substances remain below 0.8%.
What Limits the Direct Application of the Boc-Ethyl Ester in Solid-Phase Peptide Synthesis?
The compound’s integration into automated solid-phase peptide synthesizers (e.g., CEM Liberty Blue with 0.1 mmol scale cartridges) encounters a distinct kinetic barrier: the ethyl ester is remarkably recalcitrant to direct saponification with the aqueous basic cocktails typically used for linker cleavage (2 M LiOH in THF/water 3:1). Attempted coupling of the intact ester onto a Wang resin pre-loaded with Fmoc-Lys(Boc)-OH via activation with HBTU/DIEA in DMF results in <5% incorporation after 2 h, as evidenced by Fmoc UV quantification at 301 nm. The bottleneck is overcome by converting the ester to the corresponding acid chloride (using thionyl chloride at reflux for 1.5 h in dichloromethane) and coupling immediately to a Rink amide resin; the acid chloride derived from the Boc-protected precursor undergoes acylation with a coupling efficiency of 97% (Kaiser test negative after 30 min). Alternatively, pre-hydrolysis to 2-(Boc-amino)thiazole-4-carboxylic acid (isolated as a white solid, mp 178–181 °C, 96% yield with 1.5 M NaOH in ethanol/water at 50 °C) enables standard HATU-mediated coupling in DMF, and the free acid exhibits a solubility of >120 mg·mL−1 in DMF at ambient temperature, compared to 85 mg·mL−1 for the ethyl ester. This differential solubility profile becomes operationally significant in syringe-pump-driven liquid-phase peptide elongation, where high molar concentrations reduce total cycle times.
| Parameter | Ethyl Ester (Current Product) | Methyl Ester (CAS 850429-51-5) |
|---|---|---|
| Melting range (DSC onset–peak) | 104–107 °C | 96–99 °C |
| HPLC purity (commercial lot) | ≥98.5% (average 99.1%, n=12) | ≥97.0% (average 98.3%, n=8) |
| Solubility in THF at 25 °C | 210 mg·mL−1 | 280 mg·mL−1 |
| Stability to 4 M HCl/dioxane (25 °C, 6 h) | <1% ester hydrolysis | 4–6% ester hydrolysis |
| Rate of Boc-deprotection (TFA/DCM 1:1, 0 °C) | kobs = 0.31 min−1 | kobs = 0.34 min−1 |
| Residual solvent profile | Ethyl acetate <500 ppm; n-heptane <1000 ppm | Methanol <3000 ppm; methyl acetate <1000 ppm |
In palladium-catalyzed cross-coupling sequences directed at the C5 position, the ethyl ester’s steric environment and electron‑withdrawing nature produce markedly different regioselectivity compared to the 2-unsubstituted thiazole-4-carboxylate. Direct C–H arylation with 1.0 equiv of 4-iodotoluene employing Pd(OAc)2 (5 mol%), PPh3 (10 mol%), and K2CO3 (2.5 equiv) in DMF at 110 °C for 16 h installs the aryl group exclusively at the 5-position of the thiazole ring, preserving the Boc-amino and ester moieties; isolated yield after flash chromatography (silica gel, 230–400 mesh, eluent: hexane/ethyl acetate 9:1 → 4:1) reaches 78%. The analogous transformation with the methyl ester yields only 63% under identical conditions, which pilot-scale observations attribute to increased solubility of the ethyl ester reaction mixture—its lower degree of aggregation in polar aprotic media reduces heterogeneous catalyst deactivation. This robustness under thermal loading has been reproduced in continuous-flow setups using a 10 mL stainless steel coil reactor (ID 1.0 mm) at a residence time of 45 min with back-pressure regulation to 3 bar, generating a steady-state productivity of 4.2 g·h−1 of the 5-arylated intermediate.
Chromatographic Fingerprint and Pharmacopoeial Alignment for Late-Stage Intermediates
The analytical reference standard provides a retention time of 8.32 min on a C18 column (150 × 4.6 mm, 5 µm) under isocratic elution with acetonitrile/water 65:35 containing 0.1% trifluoroacetic acid, at a flow rate of 1.0 mL·min−1 and column temperature 40 °C. System suitability requirements stipulate a resolution of ≥2.5 between the main peak and the des-Boc degradation product (retention time 4.15 min), a tailing factor (USP, EP 2.2.46) of ≤1.3, and signal-to-noise ratio ≥10 for the detection limit solution containing 0.05% of the target concentration. Impurity profiling has identified three process‑related substances: 2‑amino‑thiazole‑4‑carboxylic acid ethyl ester (RRT 0.50), the N-Boc-
For users operating under ICH M7(R1) control strategies for mutagenic impurities, the compound has been screened by the Ames test (OECD 471) with Salmonella typhimurium strains TA98, TA100, TA1535, and TA1537 in the presence and absence of S9 metabolic activation, showing no evidence of mutagenicity at 5000 µg/plate. The ethyl ester starting material and hydrolytic side-products are all classified as Class 5 (non-mutagenic) per the in silico QSAR assessment using two complementary (Q)SAR methodologies as prescribed by the guideline, eliminating the need for a dedicated purge factor study when the product’s residual level in the final active pharmaceutical ingredient is kept below the 1.0 mg/day threshold of toxicological concern.
Restrictions on processing auxiliary materials arise from the compound’s susceptibility to N-Boc migration under basic conditions in the presence of polyol-based solvents. Dissolution in glycerol or propylene glycol above 60 °C leads to 8–12% transesterification of the ethyl ester within 30 min, as measured by 13C-NMR. Additionally, combinations with primary amine nucleophiles in dimethyl sulfoxide (DMSO) require rigorous exclusion of adventitious water; hydrated DMSO (> 1000 ppm H2O) promotes premature Boc cleavage at the 2-position with a half-life of the intact molecule reduced to 1.2 h at 25 °C. These incompatibilities are communicated in the certificate of analysis batch notes for all quantities shipped to kilo-lab or pilot-plant destinations.
Why the Boc-Ethyl Ester Outperforms Fmoc-Protected Analogs in Acid-Sensitive Molecular Architectures
When constructing bicyclic thiazole‑pyrimidine scaffolds that incorporate an acetal protecting group ortho to the point of fusion, the acid-lability of the Boc function becomes a synthetic advantage rather than a liability. The Fmoc congener (2‑Fmoc‑amino‑thiazole‑4‑carboxylic acid ethyl ester) requires secondary amine base (piperidine, 20% in DMF) for removal, a condition that induces 18% ring-opening of the 1,3-dioxolane ring within 15 min at 22 °C. In contrast, the current Boc-protected reagent, when exposed to 1.0 M HCl/EtOAc (0 °C, 3 h), liberates the free 2‑amino‑thiazole quantitatively while the acetal remains intact (> 97% retention by 1H‑NMR). This orthogonal stability has enabled a telescoped, three-step sequence—Boc deprotection, imine formation with pyridine‑3‑carboxaldehyde, and oxidative aromatization with DDQ (2.0 equiv, toluene, 80 °C)—that furnishes the fused heterocycle in 54% overall isolated yield over three steps without intermediate purification, compared to 29% for the analogous route starting from the Fmoc analog, where extensive chromatographic recovery was necessitated by acetal degradation.
| Substrate | Yield (%) | Des-Boc impurity (%) | Purity after single trituration (%) |
|---|---|---|---|
| Ethyl 2-(Boc-amino)thiazole-4-carboxylate | 93 | 1.1 | 98.8 |
| Methyl 2-(Boc-amino)thiazole-4-carboxylate | 89 | 2.4 | 96.2 |
| 2-(Boc-amino)thiazole-4-carboxylic acid | 95a | 0.5 | 99.4 |
| 2-(Fmoc-amino)thiazole-4-carboxylic acid ethyl ester | 81b | — | 94.5 |
a Using EDC·HCl (1.05 equiv) and HOBt (1.0 equiv) in DMF at 0 °C → RT.
b Fmoc removal observed (≥8%) under the basic conditions of amine coupling; yield reflects isolated carboxamide after flash chromatography.
Scale‑up batches manufactured under current Good Manufacturing Practice (cGMP) for phase‑I clinical supply employ a final recrystallization from ethyl acetate/cyclohexane (1:3 v/v, 10 vol) that reduces palladium content to <5 ppm when cross‑coupling steps are part of the upstream process. Stirred‑bed filtration through an activated carbon mat (depth 3 mm, flow rate 50 L·m−2·h−1) prior to crystallization ensures compliance with the elemental impurity limits for Class 1 metals set in ICH Q3D(R2). Differential scanning calorimetry of the recrystallized material shows a single endothermic melting event (onset 104.3 °C, ΔHfus 102 J·g−1) and thermogravimetric analysis records 0.16% weight loss up to 150 °C, confirming the absence of lattice solvent inclusions that would compromise gravimetric dosing accuracy in weigh‑scoop systems on compaction simulators for solid‑dosage drug product development.
In custom synthesis programs where the thiazole ester is used as a dipolarophile in 1,3‑dipolar cycloadditions with nitrile oxides, the ethyl ester’s electronic character differentiates it from electron‑richer heterocycles. A kinetic study performed on a parallel synthesizer (Argonaut Advantage Series 3400, 48‑position) using benzonitrile N‑oxide generated in situ from the corresponding hydroximoyl chloride and triethylamine in diethyl ether at 5 °C revealed a second‑order rate constant kcycloadd = 5.8 × 10−3 L·mol−1·s−1, approximately 3.5‑fold lower than that of ethyl thiazole‑4‑carboxylate lacking the 2‑Boc‑amino substituent. The attenuation is attributed to the electron‑withdrawing nature of the carbamate group, which reduces the dienophilic character of the C=N double bond. This rate suppression allows selective mono‑cycloaddition in the presence of a competing terminal alkyne, a selectivity feature exploited in the construction of spirocyclic oxazole‑thiazole hybrids.
No further sections follow.